1. Home
  2. CRNT vs KROS Comparison

CRNT vs KROS Comparison

Compare CRNT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

SELL

Current Price

$2.00

Market Cap

213.6M

Sector

Technology

ML Signal

SELL

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

SELL

Current Price

$10.89

Market Cap

222.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRNT
KROS
Founded
1996
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
222.7M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
CRNT
KROS
Price
$2.00
$10.89
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$4.83
★ $19.83
AVG Volume (30 Days)
★ 323.9K
149.4K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 146.00
EPS
★ N/A
N/A
Revenue
N/A
★ $243,864,000.00
Revenue This Year
$9.08
N/A
Revenue Next Year
$6.40
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$9.69
52 Week High
$3.29
$22.55

Technical Indicators

Market Signals
Indicator
CRNT
KROS
Relative Strength Index (RSI) 46.44 43.27
Support Level $1.90 $10.65
Resistance Level $2.18 $11.86
Average True Range (ATR) 0.08 0.50
MACD 0.00 -0.05
Stochastic Oscillator 41.54 22.51

Price Performance

Historical Comparison
CRNT
KROS

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: